BiVACOR’s Total Artificial Heart aims to become the world’s first viable alternative to heart transplants.
The fist-sized titanium device pumps blood around the body using just one moving part – a small rotor – that’s held in place magnetically, drastically reducing mechanical wear and tear, and designed for long-term use.
BiVACOR established its international R&D presence at the Gold Coast Health and Knowledge Precinct (GCHKP) in 2021 to complete final research and experimentation ahead of human trials.
‘Precincts like the GCHKP, where there’s a university, a hospital, and an innovation space within walking distance of each other, are exceptionally rare… it was a no-brainer for us to join.
‘Tapping the incredible talent from Queensland and creating more bridges between Australia and the US enables ideas to synthesise while supporting their global visualisation – something vital when bringing any big medtech idea to life'.
Dr Daniel Timms - Founder
Is your business ready to unlock global markets? Learn more about your future export success through TIQ.
Whether you are an experienced exporter looking to expand your global footprint or a new exporter starting your journey, TIQ can help you scale your business internationally.